Roth Capital sets USD 475 target for Natera stock

Published on 10/26/2026 at 17:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 752.75 million, up 37.70 percent. Natera stock costs EUR 361.75 on October 26, 2026 at 5:00 p.m. CEST.

Analyst view and operating figures

Roth Capital initiated coverage with a USD 475.00 target on October 23, 2026.
Natera reported USD 752.75 million in second-quarter 2026 revenue, up 37.70 percent year over year.
Natera stock costs EUR 361.75 at Lang & Schwarz on October 26, 2026 at 5:00 p.m. CEST.

NTRA, US6323071042, Illustration mit AI erstellt.

Natera, Inc. (ISIN US6323071042) drew a new analyst target of USD 475.00 from Roth Capital on October 23, 2026. According to Markets Insider, the firm initiated coverage with a Buy rating and cited Natera's oncology diagnostics opportunity. Natera stock was trading at EUR 361.75 at Lang & Schwarz on October 26, 2026 at 5:00 p.m. CEST.

Roth targets oncology growth

Roth Capital's target followed other recent analyst actions. Canaccord raised its Natera target to USD 500.00 from USD 375.00 on October 19, 2026, while keeping a Buy rating, according to Markets Insider. The latest target activity places attention on oncology testing and the commercial potential of Signatera.

Revenue reached USD 752.75 million

Natera's second-quarter 2026 revenue reached USD 752.75 million, up 37.70 percent from the same quarter a year earlier. The company reported an adjusted loss of USD 0.47 per share versus a USD 0.49 consensus loss, according to MarketBeat. Revenue therefore exceeded the cited USD 661.24 million expectation by USD 91.51 million.

In the October 12, 2026 earnings-call transcript, Benzinga reported that management raised full-year 2026 revenue guidance to USD 2.85 billion to USD 2.91 billion. The range implied 31.00 percent annual growth excluding revenue true-ups, while gross margin was approximately 65.00 percent in the second quarter.

Valuation remains the key question

Natera's market capitalization was USD 58.2 billion as of October 26, 2026, and its Nasdaq quote was USD 404.07 at 12:00 p.m. ET. The 52-week range was USD 181.00 to USD 437.41 on the same date. The upper end leaves the stock USD 33.34 below its yearly high, making the distance to that level a relevant measure for investors weighing the new targets against the recent trading range.

Stock trades after the Xetra session

The euro quotation gives German investors a separate trading reference from the Nasdaq price. The stock stood at EUR 361.75 at Lang & Schwarz on October 26, 2026 at 5:00 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Natera stock.